Rakovina Therapeutics Inc (TSE:RKV)

:RKV

RKV

Rakovina Therapeutics Inc

RESEARCH TOOLSreports

Want to see TSE:RKV full AI Analyst Report?

Rakovina Therapeutics Inc (RKV) Price & Analysis

22 Followers

RKV Stock Chart & Stats

C$0.10

Market closed

C$0.10

Day’s Range― - ―

52-Week RangeC$0.09 - C$0.84

Previous CloseN/A

VolumeN/A

Average Volume (3M)35.62K

Market Cap

C$2.43M

Enterprise ValueC$12.90M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.93

Next Earnings

May 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding21,148,039

10 Day Avg. Volume45,125

30 Day Avg. Volume35,623

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)1.1

Revenue Forecast (FY)C$30.00M

Rakovina Therapeutics Inc News

Rakovina leverages AI to advance next‑generation cancer drug candidates

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has issued an update. Rakovina Therapeutics will present two AI-enabled oncology programs...

1M ago

Rakovina Therapeutics Extends Private Placement to Bolster Working Capital

Rakovina Therapeutics Inc ( ($TSE:RKV) ) just unveiled an update. Rakovina Therapeutics Inc., a biopharmaceutical firm specializing in...

2M ago

Rakovina Raises $1 Million and Restructures Debt to Bolster Cancer Drug Development

Rakovina Therapeutics Inc ( ($TSE:RKV) ) just unveiled an announcement. Rakovina Therapeutics has closed a non-brokered private placement...

2M ago

Rakovina Therapeutics Upsizes Financing to $2 Million for Near-Term Operations

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has issued an announcement. Rakovina Therapeutics has upsized its previously announced financing...

2M ago

Rakovina Gains DDR Momentum with Brain-Penetrant ATR Strategy and ADC Interest

An update from Rakovina Therapeutics Inc ( ($TSE:RKV) ) is now available. At the 9th Annual DDR Inhibitors...

3M ago

Rakovina Therapeutics Moves to Bolster Finances With Debenture Deal, Equity Raise and Debt Overhaul

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has provided an update. Rakovina Therapeutics has outlined a multifaceted corporate plan...

3M ago

Rakovina and Variational AI Deepen Partnership to Fast-Track Next-Gen ATR Cancer Drugs

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has issued an announcement. Rakovina Therapeutics Inc. and Variational AI have expanded...

4M ago

Rakovina Therapeutics to Seek Strategic Partnerships During JPM Week

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has provided an update. Rakovina Therapeutics announced that its senior executives will...

5M ago

Rakovina Therapeutics to Host Webinar on AI-Driven Cancer Therapies

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has provided an update. Rakovina Therapeutics Inc. announced an upcoming webinar in...

5M ago

Rakovina Therapeutics Reports Q3 2025 Financial Results and Highlights Strategic Advances

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has provided an announcement. Rakovina Therapeutics Inc. reported a net loss of...

5M ago

RKV FAQ

What was Rakovina Therapeutics Inc’s price range in the past 12 months?

Rakovina Therapeutics Inc lowest stock price was C$0.09 and its highest was C$0.84 in the past 12 months.

What is Rakovina Therapeutics Inc’s market cap?

Rakovina Therapeutics Inc’s market cap is C$2.43M.

When is Rakovina Therapeutics Inc’s upcoming earnings report date?

Rakovina Therapeutics Inc’s upcoming earnings report date is May 21, 2026 which is in 18 days.

How were Rakovina Therapeutics Inc’s earnings last quarter?

Currently, no data Available

Is Rakovina Therapeutics Inc overvalued?

According to Wall Street analysts Rakovina Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Rakovina Therapeutics Inc pay dividends?

Rakovina Therapeutics Inc does not currently pay dividends.

What is Rakovina Therapeutics Inc’s EPS estimate?

Rakovina Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Rakovina Therapeutics Inc have?

Rakovina Therapeutics Inc has 21,148,039 shares outstanding.

What happened to Rakovina Therapeutics Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Rakovina Therapeutics Inc?

Currently, no hedge funds are holding shares in TSE:RKV

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Rakovina Therapeutics Inc

Vincero Capital Corp is a capital pool company. Its principal business is the identification and evaluation of assets or businesses, with a view to completing a qualifying transaction.